Venetoclax and hypomethylating agents (HMAs) induce high response rates in MDS, including patients after HMA therapy failure
- Resource Type
- Article
- Authors
- Ball, Brian J.; Famulare, Christopher A.; Stein, Eytan M.; Tallman, Martin S.; Derkach, Andriy; Roshal, Mikhail; Gill, Saar I.; Manning, Benjamin M.; Koprivnikar, Jamie; McCloskey, James; Testi, Rebecca; Prebet, Thomas; Al Ali, Najla H.; Padron, Eric; Sallman, David A.; Komrokji, Rami S. ; Goldberg, Aaron D.
- Source
- In Blood Advances 14 July 2020 4(13):2866-2870
- Subject
- Language
- ISSN
- 2473-9529